Margaret Moses Branch is an attorney and partner at Branch Law Firm in Albuquerque, New Mexico. She represents clients in medical malpractice, personal injury, mass torts, toxic torts, products liability, and general litigation matters. Admitted to practice in New Mexico and Colorado, she is also admitted to the U.S. Court of Appeals for the Tenth Circuit and the U.S. District Court for the District of New Mexico. Margaret earned her J.D. and B.S. from the University of New Mexico.

LATEST ARTICLES BY: Margaret Moses Branch

Avandia Clinical Trials Partially Stopped

  |     |  
Last Modified on Mar 16, 2024

Last week the Food and Drug Administration (FDA) advisory panel recommended that Avandia – a popular diabetes drug linked to a higher risk of heart attack – contain either stronger warning labels or restrict its use. Avandia is developed and manufactured by GlaxoSmithKline. In addition to a well-documented increased risk of heart attack, Avandia has… read more


Manufacturers of dangerous drugs should not be immune from liability

  |     |  
Last Modified on May 02, 2024

The Sixth Circuit Court of Appeals has recently submitted a question to the Food and Drug Administration requesting a response to its position on immunity. At issue is the claim by manufacturers that because the FDA regulates prescription drugs, once the drugs they make have received FDA “approval,” drug manufacturers cannot be held liable for… read more


FDA AVANDIA Hearing – Day Two

  |     |  
Last Modified on Mar 16, 2024

Wednesday, July 14th, 2010 Today officials meet again in Gaithersburg, Maryland to discuss the fate of the diabetes drug Avandia. FDA decision-makers are given instructions to answer multiple-choice questions that start with the following: Please select the following: A. Avandia (Rosiglitazone) should continue on the market and the black box warning should be removed. B…. read more


FDA AVANDIA Hearing – Day Two update

  |     |  
Last Modified on Mar 16, 2024

The officials voting today were presented with multiple choice questions. Question three had a choice of A. The data provides sufficient evidence to raise significant safety concerns in diabetes type 2 patients taking Rosiglitazone (Avandia). B. The data does not provide sufficient evidence to raise significant safety concerns in diabetes type 2 patients taking Avandia…. read more


FDA AVANDIA Hearing

  |     |  
Last Modified on Mar 16, 2024

Today, July 13th, 2010, the FDA is currently hosting a hearing regarding the dangerous drug Avandia. Please see our links in MEDIA to view recent news clips from CNN. As Albuquerque personal injury attorneys, we believe Avandia is harmful and consequently should be removed from the market. If you or a loved one has taken… read more


New Reports Link Avandia To Increased Risk Of Heart Attack

  |     |  
Last Modified on Mar 16, 2024

This past week new studies reported that Avandia poses a substantially greater risk of heart attacks for its users. Avandia is a diabetes drug prescribed to thousands of diabetics in New Mexico and throughout the United States. In one study, published by the AMA, researchers studied more than 227,000 people who took Avandia and found… read more



AVANDIA RECENT NEWS

  |     |  
Last Modified on Mar 16, 2024

Please see our Avandia information page to learn about the most up-to-date news on the harmful diabetes drug. The attorneys and lawyers at the Branch Law Firm can help you take action against the pharmaceutical giant Glaxo Smith Kline, makers of the diabetes drug Avandia; also known as Rosiglitazone.


DANGEROUS DRUG – Reglan

  |     |  
Last Modified on Mar 16, 2024

Reglan is a prescription drug pushed by pharmaceutical companies to patients to treat Gastroesophageal reflux (GER) Gastroesophageal reflux disease (GERD). Many studies dating back from the 1970s have shown that Reglan is ineffective in resolving GER and GERD. A 2006 study published in Nature Clinical Practice: Gastroenterology & Hepatology concluded that “the evidence base for… read more


Tragic New Mexico Car Accident Kills Cyclist

  |     |  
Last Modified on Mar 16, 2024

A 19-year old bicyclist riding cross-country to raise money for breast cancer research died after being struck by a car. He was part of a team of cyclists riding to raise money for the Susan G. Komen Foundation. The car/bike collision occurred near Laguna, New Mexico, about 50 miles west of Albuquerque. Witnesses report that… read more